Viral sepsis has been proposed as an accurate term to describe all multisystemic
dysregulations and clinical findings in severe and critically ill COVID-19 patients. The …

The pandemic of the coronavirus disease 2019 (COVID-19) has become a global public
health crisis. The symptoms of COVID-19 range from mild to severe, but the physiological …

Since the beginning of the pandemic caused by the severe acute respiratory syndrome
coronavirus 2 (SARS‐CoV‐2) the gastrointestinal (GI) tract has emerged as an important …

The biological mechanisms involved in SARS-CoV-2 infection are only partially understood.
Thus we explored the plasma metabolome of patients infected with SARS-CoV-2 to search …

COronaVIrus Disease-2019 (COVID-19) is a pandemic respiratory infection caused by a
new betacoronavirus, the Severe Acute Respiratory Syndrome-CoronaVirus-2 (SARS-CoV …

COVID-19 is a severe disease in humans, as highlighted by the current global pandemic.
Several studies about the metabolome of COVID-19 patients have revealed metabolic …

Background and Aims Coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with altered gut …

The heterogeneity in severity and outcome of COVID-19 cases points out the urgent need for
early molecular characterization of patients followed by risk-stratified care. The main …

Research exploring the development and outcome of COVID-19 infections has led to the
need to find better diagnostic and prognostic biomarkers. This cross-sectional study used …

Respiratory failure and mortality from COVID-19 result from virus-and inflammation-induced
lung tissue damage. The intestinal microbiome and associated metabolites are implicated in …